Skip to main content

Bluebird Botanicals Acquires Precision Botanical and Receives Growth Investment from Juggernaut Capital Partners

Written by Customer Service on . Posted in Mergers And Acquisitions.

LOUISVILLE, Colo., July 23, 2021 (GLOBE NEWSWIRE) — Bluebird Botanicals (“Bluebird” or the “Company”), a leading manufacturer and distributor of high-quality hemp CBD products, today announced the acquisition of Precision Botanical (“Precision”), a science-driven CBD brand that is committed to providing purity, accuracy, and transparency for all of its CBD products. The combined company will have the resources and expertise to continue producing and delivering to customers the safest, highest-quality, and most effective botanical supplements nature can provide.

Operating as one of the oldest, largest, and most recognizable CBD brands, Bluebird offers multiple CBD products including its award-winning Classic CBD Oil and alternative options such as CBD isolates and CBD gummies. With the closing of this acquisition, Bluebird continues to demonstrate its leadership in the large and fast-growing CBD industry. The merger with Precision will allow Bluebird to strengthen its supply chain, continue to adhere to a rigorous hemp extraction process for all of its products, and further establish the combined company’s brand reputation for purity, safety, and quality among retailers and consumers.

Bluebird also gains instant access to Precision’s Oregon-based hemp cultivation and extraction facility. The combined company will benefit from Precision’s key science, technology, and data-led consumer insights, as well as its patent-pending revolutionary tools and technologies, new product development opportunities, and innovative team of experts.

Brandon Beatty, the longest-tenured CEO in the CBD industry and Founder and CEO of Bluebird Botanicals, said: “Bluebird has been an industry leader since its founding, and this acquisition further solidifies our position as a world-renowned hemp extract company that is committed to the highest standards of product quality and intently focused on human wellness. We believe the combination of Bluebird’s brand recognition and customer-centric approach with Precision’s science-driven model will lift both brands to new heights. We’re extremely proud and excited to partner with the scientists who founded Precision, as well as the talented and respected folks at Juggernaut Capital Partners.”

Since its founding in 2012, Bluebird, which is a Certified B Corporation, has focused strategically on its e-commerce operations and the natural and specialty sales channels. Consistent with this focus, the combination with Precision will serve to strengthen Bluebird’s presence in brick-and-mortar retail locations, as Precision has a fast-growing national footprint within convenience and grocery store channels.

In addition to the acquisition, Bluebird has received a growth investment from Juggernaut Capital Partners, a lower middle market private equity firm specializing in buyout and growth investments across the consumer and outsourced healthcare services industries. Juggernaut’s investment will strengthen the combined company’s financial profile and provide it with the resources to fuel further innovation in the CBD space, accelerate growth online, and assist future expansion into new channels.

About Bluebird Botanicals
Founded in 2012 by Brandon Beatty, Bluebird’s vision has always been driven by the deepest respect for the hemp plant and the plethora of benefits it can provide to our global communities. Bluebird quickly became known as the company that cares and does things right, and its combination with Precision Botanical underscores and deepens this commitment. Founded by a team of neuroscientists, chemist, and toxicologists, Precision is a science-first brand committed to quality, purity, and transparency in creating the best CBD products available anywhere. With an overarching focus on quality, Bluebird is one of the largest hemp extract manufacturers and retailers in the world. After acquiring Precision, passing their current Good Manufacturing Practices audit with excellent scores, and achieving self-affirmed GRAS status, Bluebird is well-positioned to continue its growth in the large, increasingly competitive, and expanding CBD market.

For more information on Bluebird, please visit www.bluebirdbotanicals.com

About Juggernaut Capital Partners
Juggernaut Capital Partners is a lower middle market private equity firm specializing in buyout and growth investments across the consumer and outsourced healthcare services industries. Juggernaut has a family of funds representing over $1 billion of capital commitments and is currently investing out of Juggernaut Capital Partners IV, L.P.

For more information on Juggernaut Capital Partners, please visit www.juggernautcap.com

Media Contact: Zane Bader
zane@nisonco.com
470-342-5440

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.